DEPTOR Deficiency-Mediated mTORc1 Hyperactivation in Vascular Endothelial Cells Promotes Angiogenesis
Author(s) -
Yan Ding,
Lanlan Shan,
Wenqing Nai,
Xiaojun Lin,
Ling Zhou,
Xiaoying Dong,
Hongyuan Wu,
Min Xiao,
Xuejuan Zhou,
Linlin Wang,
Ting Li,
You Fu,
Yijun Lin,
Chunhong Jia,
Meng Dai,
Xiaochun Bai
Publication year - 2018
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000488619
Subject(s) - angiogenesis , cd31 , pi3k/akt/mtor pathway , vascular endothelial growth factor , mtorc1 , microbiology and biotechnology , cancer research , gene knockdown , biology , vascular endothelial growth factor a , signal transduction , cell culture , genetics , vegf receptors
The mechanistic target of rapamycin (mTOR) signaling pathway is essential for angiogenesis and embryonic development. DEP domain-containing mTOR-interacting protein (DEPTOR) is an mTOR binding protein that functions to inhibit the mTOR pathway In vitro experiments suggest that DEPTOR is crucial for vascular endothelial cell (EC) activation and angiogenic responses. However, knowledge of the effects of DEPTOR on angiogenesis in vivo is limited. This study aimed to determine the role of DEPTOR in tissue angiogenesis and to elucidate the molecular mechanisms.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom